Quaker Capital Investments Llc decreased its stake in Chemtura Corp (CHMT) by 24.05% based on its latest 2016Q3 regulatory filing with the SEC. Quaker Capital Investments Llc sold 118,408 shares as the company’s stock rose 25.23% with the market. The institutional investor held 373,840 shares of the major chemicals company at the end of 2016Q3, valued at $12.27 million, down from 492,248 at the end of the previous reported quarter. Quaker Capital Investments Llc who had been investing in Chemtura Corp for a number of months, seems to be less bullish one the $2.08B market cap company. The stock is up 0.08% or $0.03 hitting $33.08, despite the negative news. About 71,472 shares traded hands. Chemtura Corp (NYSE:CHMT) has risen 20.58% since June 7, 2016 and is uptrending. It has outperformed by 13.15% the S&P500.
Quaker Capital Investments Llc, which manages about $281.44 million US Long portfolio, upped its stake in Echostar Corp (NASDAQ:SATS) by 89,043 shares to 325,411 shares, valued at $14.26 million in 2016Q3, according to the filing.
Insitutional Activity: The institutional sentiment decreased to 0.76 in 2016 Q3. Its down 0.37, from 1.13 in 2016Q2. The ratio worsened, as 39 funds sold all CHMT shares owned while 75 reduced positions. 42 funds bought stakes while 45 increased positions. They now own 54.78 million shares or 3.83% less from 56.96 million shares in 2016Q2. Herndon Management Ltd Llc accumulated 0% or 187 shares. Capstone Inv Advsrs Ltd Co last reported 0.09% of its portfolio in the stock. Moreover, Alliancebernstein Limited Partnership has 0% invested in Chemtura Corp (NYSE:CHMT) for 116,205 shares. The California-based California Employees Retirement Systems has invested 0.02% in Chemtura Corp (NYSE:CHMT). Prudential Fincl Inc holds 30,157 shares or 0% of its portfolio. The Ontario – Canada-based Omers Administration has invested 0.25% in Chemtura Corp (NYSE:CHMT). Highlander Llc accumulated 0.03% or 1,000 shares. Dupont Cap Mgmt reported 18,400 shares or 0.01% of all its holdings. First Manhattan has 2 shares for 0% of their US portfolio. Moreover, Manchester Management has 0.05% invested in Chemtura Corp (NYSE:CHMT) for 10,842 shares. Ladenburg Thalmann Svcs last reported 668 shares in the company. State Street accumulated 1.26 million shares or 0.01% of the stock. Fny Managed Accounts Ltd holds 0% of its portfolio in Chemtura Corp (NYSE:CHMT) for 200 shares. Keeley Asset, a Illinois-based fund reported 785,947 shares. The United Kingdom-based Barclays Public Ltd has invested 0% in Chemtura Corp (NYSE:CHMT).
Insider Transactions: Since August 16, 2016, the stock had 0 buys, and 3 selling transactions for $436,815 net activity. $348,608 worth of Chemtura Corp (NYSE:CHMT) shares were sold by MEDLEY SIMON D.. The insider Puri Dalip sold 1,900 shares worth $59,812.
Analysts await Chemtura Corp (NYSE:CHMT) to report earnings on February, 27. They expect $0.43 EPS, down 2.27% or $0.01 from last year’s $0.44 per share. CHMT’s profit will be $27.04 million for 19.23 P/E if the $0.43 EPS becomes a reality. After $0.52 actual EPS reported by Chemtura Corp for the previous quarter, Wall Street now forecasts -17.31% negative EPS growth.
More recent Chemtura Corp (NYSE:CHMT) news were published by: Fool.com which released: “Why Chemtura Corp.’s Shares Popped 16% Today” on September 26, 2016. Also Pionline.com published the news titled: “Chemtura Corp. enters into buyout with Voya” on February 23, 2016. Natlawreview.com‘s news article titled: “Lanxess AG and Chemtura Corp: Upcoming/New CFIUS Filing” with publication date: October 13, 2016 was also an interesting one.
According to Zacks Investment Research, “Chemtura Corporation is a global manufacturer and marketer of specialty chemicals, crop protection and pool, spa and home care products.”
Chemtura Corp (NYSE:CHMT) Ratings Coverage
Out of 6 analysts covering Chemtura (NYSE:CHMT), 1 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 17% are positive. Chemtura has been the topic of 11 analyst reports since October 29, 2015 according to StockzIntelligence Inc. The stock of Chemtura Corp (NYSE:CHMT) has “Hold” rating given on Thursday, November 3 by Gabelli. The firm has “Sector Weight” rating given on Monday, October 17 by KeyBanc Capital Markets. The rating was downgraded by Seaport Global Securities on Monday, October 3 to “Neutral”. As per Tuesday, September 27, the company rating was downgraded by Gabelli. KeyBanc Capital Markets upgraded Chemtura Corp (NYSE:CHMT) on Tuesday, April 5 to “Overweight” rating. On Friday, October 30 the stock rating was upgraded by Seaport Global Securities to “Buy”. The stock of Chemtura Corp (NYSE:CHMT) has “Neutral” rating given on Monday, September 26 by SunTrust. BB&T Capital upgraded the shares of CHMT in a report on Tuesday, April 26 to “Buy” rating. As per Friday, September 9, the company rating was downgraded by Robert W. Baird.
CHMT Company Profile
Chemtura Corporation, incorporated on May 27, 1999, is a developer, maker and marketer of engineered industrial specialty chemicals. The Company’s products are sold to industrial manufacturing clients for use as additives, ingredients or intermediates that add value to their end products. The Firm operates through two divisions: Industrial Performance Products and Industrial Engineered Products. The Company’s Industrial Performance Products segment is a maker and marketer of lubricant additive components, synthetic lubricant base-stocks, synthetic finished fluids, calcium sulfonate specialty greases and phosphate and polyester fluids, and is also engaged in the development and production of hot cast elastomer pre-polymers. The Company’s Industrial Engineered Products segment is a developer and maker of bromine and bromine products and organometallic compounds. The Firm operates in a range of end-use industries, including automotive, building and construction, electronics, lubricants, packaging and transportation. It operates in North America, Europe and Asia, Asia/Pacific and Latin America.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.